AHP: THE RIGHT DIAGNOSIS IS THE ONLY WAY OUT

Acute hepatic porphyria (AHP) is a family of rare genetic diseases with an estimated EU prevalence of 5,4 per million. However, the prevalence of some types of AHP may be higher than generally assumed. It can be characterized by potentially life-threatening attacks and, for some patients, chronic debilitating symptoms that negatively impact daily functioning and quality of life. Some patients may even be at risk for progressive irreversible neuropathy.1-8

Symptoms can often resemble those of other more common diseases such as irritable bowel syndrome, fibromyalgia, endometriosis, or even certain psychiatric disorders. Consequently, patients afflicted with AHP are often misdiagnosed or remain undiagnosed for up to 15 years.5,8-10

SIGN UP to receive updates about Acute Hepatic Porphyria from Alnylam

All fields are required

* Please enter first name
* Please enter last name
* Please enter your Work Postcode
* Please select country
* Please select a medical specialization
* Please select a professional designation
* Please confirm the terms